Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort study  Dr Edward Green, MRCP, Luke Hunt,

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Epidemiology of traumatic brain injuries in Europe: a cross-sectional analysis  Dr Marek Majdan, PhD, Dominika Plancikova, MSc, Alexandra Brazinova, PhD,
Volume 14, Issue 4, Pages (April 2013)
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration  Alasdair Reid, MD, Fabio Scano,
BMI and risk of dementia in two million people over two decades: a retrospective cohort study  Dr Nawab Qizilbash, MRCP, John Gregson, PhD, Michelle E.
Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis 
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study  Dr Andrew C Hayward, MD, Ellen B.
UK investments in global infectious disease research 1997–2010: a case study  Michael G Head, PGDip, Joseph R Fitchett, MSc, Mary K Cooke, MSc, Fatima.
Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities  Dr Mateusz M Plucinski,
Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive.
Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study 
Dizziness in older adults
Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial  Prof Mark C Steinhoff, MD, Prof Joanne Katz,
Thank God for Richard Dawkins?
Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study 
Distinctly different purpura on different arms
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Volume 14, Issue 4, Pages (April 2013)
Volume 377, Issue 9783, Pages (June 2011)
Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: a longitudinal cohort study.
Controlling Ebola: key role of Ebola treatment centres
Volume 7, Issue 2, Pages (February 2008)
Volume 371, Issue 9611, Pages (February 2008)
John N Nkengasong, Philip Onyebujoh  The Lancet 
Volume 4, Issue 10, Pages e457-e464 (October 2017)
Volume 9, Issue 12, Pages (December 2010)
Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities  Dr Mateusz M Plucinski,
Volume 366, Issue 9486, Pages (August 2005)
A twin with Cushing's disease
Ebola superspreading The Lancet Infectious Diseases
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study  Matthew Waxman, MD,
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants:
Volume 379, Issue 9811, Pages (January 2012)
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study  Dr Andrew C Hayward, MD, Ellen B.
Volume 382, Issue 9903, Pages (November 2013)
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study  Dr Danielle V Clark, PhD, Hannah Kibuuka, MD, Monica.
Strengthening capacity for health research in Africa
Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort.
Antibiotic prescription strategies for acute sore throat: a prospective observational cohort study  Prof Paul Little, FMedSci, Beth Stuart, Prof F D Richard.
Volume 379, Issue 9814, Pages (February 2012)
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study  Julia Granerod,
Volume 11, Issue 8, Pages (August 2012)
Challenges to eliminate rabies virus infection in China by 2020
Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis  Ulla Beijer, PhD, Achim Wolf, MSc, Dr.
Resuscitation at birth and cognition at 8 years of age: a cohort study
Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive.
UK investments in global infectious disease research 1997–2010: a case study  Michael G Head, PGDip, Joseph R Fitchett, MSc, Mary K Cooke, MSc, Fatima.
Community-based care of Ebola virus disease in west Africa
Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational.
Amanda Rojek, MBBS, Prof Peter Horby, FRCP, Dr Jake Dunning, MRCP 
Volume 379, Issue 9812, Pages (January 2012)
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Telling it like it isn't: truth and lies in a post-9/11 world
Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)
Volume 3, Issue 9, Pages e431-e440 (September 2016)
Volume 371, Issue 9614, Pages (March 2008)
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial  Dr.
Thank God for Richard Dawkins?
Low-technology approaches
The emotional journey of gestational diabetes
Volume 386, Issue 10005, Pages (October 2015)
Volume 377, Issue 9773, Pages (April 2011)
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational.
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers  Dr Michael Jacobs, FRCP,
A remarkable report card on progress in COPD
Epidemiology of traumatic brain injuries in Europe: a cross-sectional analysis  Dr Marek Majdan, PhD, Dominika Plancikova, MSc, Alexandra Brazinova, PhD,
Volume 371, Issue 9611, Pages (February 2008)
Presentation transcript:

Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort study  Dr Edward Green, MRCP, Luke Hunt, MBChB, J C Gareth Ross, BSc, Nina Marie Nissen, BSc, Tanya Curran, PhD, Anjna Badhan, PhD, Katherine A Sutherland, PhD, Jade Richards, James S Lee, MD, Samuel H Allen, FRCP, Steven Laird, MRCP, Mandy Blackman, Ian Collacott, BSc, Paul A Parker, BSc, Andrew Walbridge, MSc, Rebecca Phillips, BSc, Sia Jammie Sellu, Agnes Dama, Alpha Karim Sheriff, MBChB, Joseph Zombo, Doris Ngegba, Alieh H Wurie, MD, Francesco Checchi, PhD, Timothy J Brooks, FRCPath  The Lancet Infectious Diseases  Volume 16, Issue 9, Pages 1052-1056 (September 2016) DOI: 10.1016/S1473-3099(16)30060-3 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 Age distribution of study participants The Lancet Infectious Diseases 2016 16, 1052-1056DOI: (10.1016/S1473-3099(16)30060-3) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 2 Distribution of length of stay in the Ebola treatment unit for participants with acute Ebola virus disease The Lancet Infectious Diseases 2016 16, 1052-1056DOI: (10.1016/S1473-3099(16)30060-3) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 3 Distribution of time from discharge from Ebola treatment unit to collection of specimens The Lancet Infectious Diseases 2016 16, 1052-1056DOI: (10.1016/S1473-3099(16)30060-3) Copyright © 2016 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.